Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4130 stock hub

TPEX/4130 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4130is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4130

In the news

Latest news · TPEX/4130

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E272

P25 14.4P50 18P75 31.9

ROE0.8

P25 -16.2P50 0.3P75 9.8

ROIC0.7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4130 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

TWD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	190
Employees Change	-5%
Employees Change Percent	-2.56
Enterprise value	TWD 2.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004130000
Last refreshed	2026-05-10
Market cap	TWD 3.1B
Price	TWD 27.2
Price currency	TWD
Rev Per Employee	2,591,610.53x
Sector	Healthcare
Sic	2834
Symbol	tpex/4130
Website	https://www.genovate-bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.38%
EV Earnings	223.75x
EV/EBITDA	64x
EV/FCF	-218.97x
EV/Sales	5.31x
FCF yield	-0.39%
P/B ratio	2.24x
P/E ratio	272x
P/S ratio	6.28x
PE Ratio10 Y	323.57x
PE Ratio3 Y	153.07x
PE Ratio5 Y	639.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.4%
EBITDA Margin	8.54%
Gross margin	35.95%
Gross Profit	TWD 177M
Gross Profit Growth	-8.11%
Gross Profit Growth Q	3.88%
Gross Profit Growth3 Y	4.56%
Gross Profit Growth5 Y	-1.72%
Net Income	TWD 11.7M
Net Income Growth	-54.54%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth5 Y	-21.32%
Pretax Margin	2.73%
Profit Margin	2.37%
Profit Per Employee	TWD 61,484
Profitable Years	3
ROA	0.28
Roa5y	0.33
ROCE	0.5
ROE	0.83
Roe5y	0.75
ROIC	0.66
Roic5y	0.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.44%
Cagr15y	4.9%
Cagr1y	37.49%
Cagr3y	0.19%
Cagr5y	3.46%
Div CAGR10	-13.69%
Div CAGR3	-15.64%
Div CAGR5	-23.84%
EPS Growth	-54.55
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth5 Y	-21.79
OCF Growth	-20.55%
OCF Growth Q	450.21%
OCF Growth10 Y	3.02%
OCF Growth3 Y	207.23%
OCF Growth5 Y	-12.85%
Revenue Growth	-3.61x
Revenue Growth Q	1x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	3.92x
Revenue Growth5 Y	0.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.32
Assets	TWD 1.5B
Cash	TWD 482M
Current Assets	TWD 719.3M
Current Liabilities	TWD 125.3M
Debt	TWD 1.8M
Debt EBITDA	TWD 0.04
Debt Equity	TWD 0
Debt FCF	TWD -0.15
Equity	TWD 1.4B
Interest Coverage	10.15
Liabilities	TWD 126M
Long Term Assets	TWD 787.1M
Long Term Liabilities	TWD 727,000
Net Cash	TWD 480.1M
Net Cash By Market Cap	TWD 15.52
Net Cash Growth	-7.47%
Net Debt EBITDA	TWD -11.42
Net Debt Equity	TWD -0.35
Tangible Book Value	TWD 1.4B
Tangible Book Value Per Share	TWD 12.08
WACC	4.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.74
Inventory Turnover	2.18
Net Working Capital	TWD 113.3M
Quick ratio	4.54
Working Capital	TWD 594M
Working Capital Turnover	TWD 0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.81%
Dividend Growth	-32%
Dividend Growth Years	0%
Dividend per share	TWD 0.1
Dividend Years	13
Dividend Yield	0.36%
Ex Div Date	2025-08-20
Last Dividend	TWD 0.1
Payout Frequency	Annual
Payout Ratio	95.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-21.89%
1Y total return	37.46%
200-day SMA	25.31
3Y total return	0.58%
50-day SMA	31.58
50-day SMA vs 200-day SMA	50over200
5Y total return	18.52%
All Time High	69.36
All Time High Change	-60.78%
All Time High Date	2014-07-18
All Time Low	6.47
All Time Low Change	320.73%
All Time Low Date	2008-12-26
ATR	1.22
Beta	0.09
Beta1y	-0.17
Beta2y	0.17
Ch YTD	-1.81
High	27.4
High52	40.15
High52 Date	2026-01-13
High52ch	-32.25%
Low	27
Low52	17.65
Low52 Date	2025-08-01
Low52ch	54.13%
Ma50ch	-13.88%
Price vs 200-day SMA	7.46%
RSI	32.67
RSI Monthly	54.73
RSI Weekly	48.18
Sharpe ratio	0.91x
Sortino ratio	1.59
Total Return	1.17%
Tr YTD	1.39
Tr15y	105.06%
Tr1m	-21.61%
Tr1w	1.3%
Tr3m	-14.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 6.9M
Operating Income Growth	-70.49
Operating Income Growth5 Y	-29.43
Operating margin	1.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,107,071%
Net Borrowing	-916,000
Shares Insiders	0.42%
Shares Institutions	1.28%
Shares Out	113,750,400
Shares Qo Q	0%
Shares Yo Y	-0.81%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -11.9M
Average Volume	947,255x
Bv Per Share	12.13
CAPEX	TWD -55.7M
Ch10y	-32.72
Ch15y	71.52
Ch1m	-21.61
Ch1w	1.3
Ch1y	32.43
Ch3m	-14.33
Ch3y	-4.27
Ch5y	9.37
Ch6m	18.78
Change	-0.55%
Change From Open	-0.55
Close	27.35
Days Gap	0
Depreciation Amortization	35,115,000
Dollar Volume	3,197,577.6
Earnings Date	2026-04-02
EBIT	TWD 6.9M
EBITDA	TWD 42M
EPS	TWD 0.1
F Score	5
FCF	TWD -11.9M
FCF EV Yield	-0.46x
FCF Per Share	TWD -0.1
Financing CF	-12,022,000
Fiscal Year End	December
Founded	1,982
Graham Number	5.22523
Graham Upside	-80.79
Income Tax	TWD 1.8M
Investing CF	-84,328,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Last Split Date	2025-08-20
Last Split Type	Forward
Lynch Fair Value	TWD 0.5
Lynch Upside	-98.16
Ma150	27.59
Ma150ch	-1.42%
Ma20	30.02
Ma20ch	-9.39%
Net CF	-52,561,000
Open	27.35
P OCF Ratio	70.66
Payment Date	2025-09-24
Position In Range	50
Ppne	410,424,000
Price Date	2026-05-08
Price EBITDA	TWD 73.61
Ptbv Ratio	2.25
Relative Volume	0.12x
Revenue	492,406,000x
Tax By Revenue	0.36x
Tax Rate	13.17%
Tr6m	22.64%
Volume	117,558
Z Score	12.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4130 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.10 annual per share

Payout ratio

+95.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-23.8%

0 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2025-08-20

Performance

TPEX/4130 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4130?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.3%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

TPEX/4130 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.7

Neutral momentum band

Price vs 200-day MA

+7.5%

50/200-day relationship not available

Beta (5Y)

0.09

Less volatile than the market

Sharpe ratio

0.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4130

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4130 stock rating?

tpex/4130 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4130 analysis?

The full report lives at /stocks/tpex/4130/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4130?

The latest report frames tpex/4130 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4130 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.